Molecular diagnostics is the application of medical and microbiological technologies to the medical imaging science, in order to analyze biological markers present in the proteome and genome, which also includes the study of how an individual express his/her genes as proteins. The is an important diagnostic and patient monitoring technique, which not only diagnose the disease but also access the risks involved in treatment and suggest suitable therapies for the patients. Nucleic acid test, or nucleic acid amplification test (NAT/NAAT) is another molecular technology used in identification of a bacterium or virus. NAT comprises of all the tests and technologies used to identify genetic material of infecting virus or organism.
This report aims to provide a comprehensive presentation of the global market for Molecular Diagnostics and NAT, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnostics and NAT. This report contains market size and forecasts of Molecular Diagnostics and NAT in global, including the following market information:
Global Molecular Diagnostics and NAT Market Revenue, 2018-2023, 2024-2035, ($ millions)
Global top five companies in 2022 (%)
The global Molecular Diagnostics and NAT market was valued at US$ million in 2022 and is projected to reach US$ million by 2035, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
At present, the North American region is the most prominent market, owing to extensive diagnostic practices and R&D. However, Asia-Pacific and some countries in RoW region are expected to show very lucrative growth in the upcoming period, owing to enhanced awareness and growth in research and diagnostic technologies.
We surveyed the Molecular Diagnostics and NAT companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Molecular Diagnostics and NAT Market, by Type, 2018-2023, 2024-2035 ($ millions)
Global Molecular Diagnostics and NAT Market Segment Percentages, by Type, 2022 (%)
Amplification Technologies
Amplified Gene Detection Technologies
DNA And Oligonucleotide Microarrays
Gene Sequencing
Global Molecular Diagnostics and NAT Market, by Application, 2018-2023, 2024-2035 ($ millions)
Global Molecular Diagnostics and NAT Market Segment Percentages, by Application, 2022 (%)
Hospitals and Clinics
Research Institutes
Diagnostic Centers
Global Molecular Diagnostics and NAT Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions)
Global Molecular Diagnostics and NAT Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Molecular Diagnostics and NAT revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Molecular Diagnostics and NAT revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Abbott
BD
Biomerieux
Qiagen
Thermo Fisher Scientific
Agilent
GenMark
Siemens Healthcare
AutoGenomics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Molecular Diagnostics and NAT, market overview.
Chapter 2: Global Molecular Diagnostics and NAT market size in revenue.
Chapter 3: Detailed analysis of Molecular Diagnostics and NAT company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Molecular Diagnostics and NAT in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Molecular Diagnostics and NAT Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Molecular Diagnostics and NAT Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Molecular Diagnostics and NAT Overall Market Size
2.1 Global Molecular Diagnostics and NAT Market Size: 2022 VS 2035
2.2 Global Molecular Diagnostics and NAT Market Size, Prospects & Forecasts: 2018-2035
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Molecular Diagnostics and NAT Players in Global Market
3.2 Top Global Molecular Diagnostics and NAT Companies Ranked by Revenue
3.3 Global Molecular Diagnostics and NAT Revenue by Companies
3.4 Top 3 and Top 5 Molecular Diagnostics and NAT Companies in Global Market, by Revenue in 2022
3.5 Global Companies Molecular Diagnostics and NAT Product Type
3.6 Tier 1, Tier 2 and Tier 3 Molecular Diagnostics and NAT Players in Global Market
3.6.1 List of Global Tier 1 Molecular Diagnostics and NAT Companies
3.6.2 List of Global Tier 2 and Tier 3 Molecular Diagnostics and NAT Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Molecular Diagnostics and NAT Market Size Markets, 2022 & 2035
4.1.2 Amplification Technologies
4.1.3 Amplified Gene Detection Technologies
4.1.4 DNA And Oligonucleotide Microarrays
4.1.5 Gene Sequencing
4.2 By Type - Global Molecular Diagnostics and NAT Revenue & Forecasts
4.2.1 By Type - Global Molecular Diagnostics and NAT Revenue, 2018-2023
4.2.2 By Type - Global Molecular Diagnostics and NAT Revenue, 2024-2035
4.2.3 By Type - Global Molecular Diagnostics and NAT Revenue Market Share, 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Molecular Diagnostics and NAT Market Size, 2022 & 2035
5.1.2 Hospitals and Clinics
5.1.3 Research Institutes
5.1.4 Diagnostic Centers
5.2 By Application - Global Molecular Diagnostics and NAT Revenue & Forecasts
5.2.1 By Application - Global Molecular Diagnostics and NAT Revenue, 2018-2023
5.2.2 By Application - Global Molecular Diagnostics and NAT Revenue, 2024-2035
5.2.3 By Application - Global Molecular Diagnostics and NAT Revenue Market Share, 2018-2035
6 Sights by Region
6.1 By Region - Global Molecular Diagnostics and NAT Market Size, 2022 & 2035
6.2 By Region - Global Molecular Diagnostics and NAT Revenue & Forecasts
6.2.1 By Region - Global Molecular Diagnostics and NAT Revenue, 2018-2023
6.2.2 By Region - Global Molecular Diagnostics and NAT Revenue, 2024-2035
6.2.3 By Region - Global Molecular Diagnostics and NAT Revenue Market Share, 2018-2035
6.3 North America
6.3.1 By Country - North America Molecular Diagnostics and NAT Revenue, 2018-2035
6.3.2 US Molecular Diagnostics and NAT Market Size, 2018-2035
6.3.3 Canada Molecular Diagnostics and NAT Market Size, 2018-2035
6.3.4 Mexico Molecular Diagnostics and NAT Market Size, 2018-2035
6.4 Europe
6.4.1 By Country - Europe Molecular Diagnostics and NAT Revenue, 2018-2035
6.4.2 Germany Molecular Diagnostics and NAT Market Size, 2018-2035
6.4.3 France Molecular Diagnostics and NAT Market Size, 2018-2035
6.4.4 U.K. Molecular Diagnostics and NAT Market Size, 2018-2035
6.4.5 Italy Molecular Diagnostics and NAT Market Size, 2018-2035
6.4.6 Russia Molecular Diagnostics and NAT Market Size, 2018-2035
6.4.7 Nordic Countries Molecular Diagnostics and NAT Market Size, 2018-2035
6.4.8 Benelux Molecular Diagnostics and NAT Market Size, 2018-2035
6.5 Asia
6.5.1 By Region - Asia Molecular Diagnostics and NAT Revenue, 2018-2035
6.5.2 China Molecular Diagnostics and NAT Market Size, 2018-2035
6.5.3 Japan Molecular Diagnostics and NAT Market Size, 2018-2035
6.5.4 South Korea Molecular Diagnostics and NAT Market Size, 2018-2035
6.5.5 Southeast Asia Molecular Diagnostics and NAT Market Size, 2018-2035
6.5.6 India Molecular Diagnostics and NAT Market Size, 2018-2035
6.6 South America
6.6.1 By Country - South America Molecular Diagnostics and NAT Revenue, 2018-2035
6.6.2 Brazil Molecular Diagnostics and NAT Market Size, 2018-2035
6.6.3 Argentina Molecular Diagnostics and NAT Market Size, 2018-2035
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Molecular Diagnostics and NAT Revenue, 2018-2035
6.7.2 Turkey Molecular Diagnostics and NAT Market Size, 2018-2035
6.7.3 Israel Molecular Diagnostics and NAT Market Size, 2018-2035
6.7.4 Saudi Arabia Molecular Diagnostics and NAT Market Size, 2018-2035
6.7.5 UAE Molecular Diagnostics and NAT Market Size, 2018-2035
7 Molecular Diagnostics and NAT Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Molecular Diagnostics and NAT Major Product Offerings
7.1.4 Roche Molecular Diagnostics and NAT Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Abbott
7.2.1 Abbott Company Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Molecular Diagnostics and NAT Major Product Offerings
7.2.4 Abbott Molecular Diagnostics and NAT Revenue in Global Market (2018-2023)
7.2.5 Abbott Key News & Latest Developments
7.3 BD
7.3.1 BD Company Summary
7.3.2 BD Business Overview
7.3.3 BD Molecular Diagnostics and NAT Major Product Offerings
7.3.4 BD Molecular Diagnostics and NAT Revenue in Global Market (2018-2023)
7.3.5 BD Key News & Latest Developments
7.4 Biomerieux
7.4.1 Biomerieux Company Summary
7.4.2 Biomerieux Business Overview
7.4.3 Biomerieux Molecular Diagnostics and NAT Major Product Offerings
7.4.4 Biomerieux Molecular Diagnostics and NAT Revenue in Global Market (2018-2023)
7.4.5 Biomerieux Key News & Latest Developments
7.5 Qiagen
7.5.1 Qiagen Company Summary
7.5.2 Qiagen Business Overview
7.5.3 Qiagen Molecular Diagnostics and NAT Major Product Offerings
7.5.4 Qiagen Molecular Diagnostics and NAT Revenue in Global Market (2018-2023)
7.5.5 Qiagen Key News & Latest Developments
7.6 Thermo Fisher Scientific
7.6.1 Thermo Fisher Scientific Company Summary
7.6.2 Thermo Fisher Scientific Business Overview
7.6.3 Thermo Fisher Scientific Molecular Diagnostics and NAT Major Product Offerings
7.6.4 Thermo Fisher Scientific Molecular Diagnostics and NAT Revenue in Global Market (2018-2023)
7.6.5 Thermo Fisher Scientific Key News & Latest Developments
7.7 Agilent
7.7.1 Agilent Company Summary
7.7.2 Agilent Business Overview
7.7.3 Agilent Molecular Diagnostics and NAT Major Product Offerings
7.7.4 Agilent Molecular Diagnostics and NAT Revenue in Global Market (2018-2023)
7.7.5 Agilent Key News & Latest Developments
7.8 GenMark
7.8.1 GenMark Company Summary
7.8.2 GenMark Business Overview
7.8.3 GenMark Molecular Diagnostics and NAT Major Product Offerings
7.8.4 GenMark Molecular Diagnostics and NAT Revenue in Global Market (2018-2023)
7.8.5 GenMark Key News & Latest Developments
7.9 Siemens Healthcare
7.9.1 Siemens Healthcare Company Summary
7.9.2 Siemens Healthcare Business Overview
7.9.3 Siemens Healthcare Molecular Diagnostics and NAT Major Product Offerings
7.9.4 Siemens Healthcare Molecular Diagnostics and NAT Revenue in Global Market (2018-2023)
7.9.5 Siemens Healthcare Key News & Latest Developments
7.10 AutoGenomics
7.10.1 AutoGenomics Company Summary
7.10.2 AutoGenomics Business Overview
7.10.3 AutoGenomics Molecular Diagnostics and NAT Major Product Offerings
7.10.4 AutoGenomics Molecular Diagnostics and NAT Revenue in Global Market (2018-2023)
7.10.5 AutoGenomics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Molecular Diagnostics and NAT Market Opportunities & Trends in Global Market
Table 2. Molecular Diagnostics and NAT Market Drivers in Global Market
Table 3. Molecular Diagnostics and NAT Market Restraints in Global Market
Table 4. Key Players of Molecular Diagnostics and NAT in Global Market
Table 5. Top Molecular Diagnostics and NAT Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Molecular Diagnostics and NAT Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Molecular Diagnostics and NAT Revenue Share by Companies, 2018-2023
Table 8. Global Companies Molecular Diagnostics and NAT Product Type
Table 9. List of Global Tier 1 Molecular Diagnostics and NAT Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Molecular Diagnostics and NAT Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Molecular Diagnostics and NAT Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Molecular Diagnostics and NAT Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Molecular Diagnostics and NAT Revenue in Global (US$, Mn), 2024-2035
Table 14. By Application ? Global Molecular Diagnostics and NAT Revenue, (US$, Mn), 2022 & 2035
Table 15. By Application - Molecular Diagnostics and NAT Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Molecular Diagnostics and NAT Revenue in Global (US$, Mn), 2024-2035
Table 17. By Region ? Global Molecular Diagnostics and NAT Revenue, (US$, Mn), 2022 & 2035
Table 18. By Region - Global Molecular Diagnostics and NAT Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Molecular Diagnostics and NAT Revenue (US$, Mn), 2024-2035
Table 20. By Country - North America Molecular Diagnostics and NAT Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Molecular Diagnostics and NAT Revenue, (US$, Mn), 2024-2035
Table 22. By Country - Europe Molecular Diagnostics and NAT Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Molecular Diagnostics and NAT Revenue, (US$, Mn), 2024-2035
Table 24. By Region - Asia Molecular Diagnostics and NAT Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Molecular Diagnostics and NAT Revenue, (US$, Mn), 2024-2035
Table 26. By Country - South America Molecular Diagnostics and NAT Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Molecular Diagnostics and NAT Revenue, (US$, Mn), 2024-2035
Table 28. By Country - Middle East & Africa Molecular Diagnostics and NAT Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Molecular Diagnostics and NAT Revenue, (US$, Mn), 2024-2035
Table 30. Roche Company Summary
Table 31. Roche Molecular Diagnostics and NAT Product Offerings
Table 32. Roche Molecular Diagnostics and NAT Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Key News & Latest Developments
Table 34. Abbott Company Summary
Table 35. Abbott Molecular Diagnostics and NAT Product Offerings
Table 36. Abbott Molecular Diagnostics and NAT Revenue (US$, Mn) & (2018-2023)
Table 37. Abbott Key News & Latest Developments
Table 38. BD Company Summary
Table 39. BD Molecular Diagnostics and NAT Product Offerings
Table 40. BD Molecular Diagnostics and NAT Revenue (US$, Mn) & (2018-2023)
Table 41. BD Key News & Latest Developments
Table 42. Biomerieux Company Summary
Table 43. Biomerieux Molecular Diagnostics and NAT Product Offerings
Table 44. Biomerieux Molecular Diagnostics and NAT Revenue (US$, Mn) & (2018-2023)
Table 45. Biomerieux Key News & Latest Developments
Table 46. Qiagen Company Summary
Table 47. Qiagen Molecular Diagnostics and NAT Product Offerings
Table 48. Qiagen Molecular Diagnostics and NAT Revenue (US$, Mn) & (2018-2023)
Table 49. Qiagen Key News & Latest Developments
Table 50. Thermo Fisher Scientific Company Summary
Table 51. Thermo Fisher Scientific Molecular Diagnostics and NAT Product Offerings
Table 52. Thermo Fisher Scientific Molecular Diagnostics and NAT Revenue (US$, Mn) & (2018-2023)
Table 53. Thermo Fisher Scientific Key News & Latest Developments
Table 54. Agilent Company Summary
Table 55. Agilent Molecular Diagnostics and NAT Product Offerings
Table 56. Agilent Molecular Diagnostics and NAT Revenue (US$, Mn) & (2018-2023)
Table 57. Agilent Key News & Latest Developments
Table 58. GenMark Company Summary
Table 59. GenMark Molecular Diagnostics and NAT Product Offerings
Table 60. GenMark Molecular Diagnostics and NAT Revenue (US$, Mn) & (2018-2023)
Table 61. GenMark Key News & Latest Developments
Table 62. Siemens Healthcare Company Summary
Table 63. Siemens Healthcare Molecular Diagnostics and NAT Product Offerings
Table 64. Siemens Healthcare Molecular Diagnostics and NAT Revenue (US$, Mn) & (2018-2023)
Table 65. Siemens Healthcare Key News & Latest Developments
Table 66. AutoGenomics Company Summary
Table 67. AutoGenomics Molecular Diagnostics and NAT Product Offerings
Table 68. AutoGenomics Molecular Diagnostics and NAT Revenue (US$, Mn) & (2018-2023)
Table 69. AutoGenomics Key News & Latest Developments
List of Figures
Figure 1. Molecular Diagnostics and NAT Segment by Type in 2022
Figure 2. Molecular Diagnostics and NAT Segment by Application in 2022
Figure 3. Global Molecular Diagnostics and NAT Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Molecular Diagnostics and NAT Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Molecular Diagnostics and NAT Revenue, 2018-2035 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Molecular Diagnostics and NAT Revenue in 2022
Figure 8. By Type - Global Molecular Diagnostics and NAT Revenue Market Share, 2018-2035
Figure 9. By Application - Global Molecular Diagnostics and NAT Revenue Market Share, 2018-2035
Figure 10. By Type - Global Molecular Diagnostics and NAT Revenue, (US$, Mn), 2022 & 2035
Figure 11. By Type - Global Molecular Diagnostics and NAT Revenue Market Share, 2018-2035
Figure 12. By Application - Global Molecular Diagnostics and NAT Revenue, (US$, Mn), 2022 & 2035
Figure 13. By Application - Global Molecular Diagnostics and NAT Revenue Market Share, 2018-2035
Figure 14. By Region - Global Molecular Diagnostics and NAT Revenue Market Share, 2018-2035
Figure 15. By Country - North America Molecular Diagnostics and NAT Revenue Market Share, 2018-2035
Figure 16. US Molecular Diagnostics and NAT Revenue, (US$, Mn), 2018-2035
Figure 17. Canada Molecular Diagnostics and NAT Revenue, (US$, Mn), 2018-2035
Figure 18. Mexico Molecular Diagnostics and NAT Revenue, (US$, Mn), 2018-2035
Figure 19. By Country - Europe Molecular Diagnostics and NAT Revenue Market Share, 2018-2035
Figure 20. Germany Molecular Diagnostics and NAT Revenue, (US$, Mn), 2018-2035
Figure 21. France Molecular Diagnostics and NAT Revenue, (US$, Mn), 2018-2035
Figure 22. U.K. Molecular Diagnostics and NAT Revenue, (US$, Mn), 2018-2035
Figure 23. Italy Molecular Diagnostics and NAT Revenue, (US$, Mn), 2018-2035
Figure 24. Russia Molecular Diagnostics and NAT Revenue, (US$, Mn), 2018-2035
Figure 25. Nordic Countries Molecular Diagnostics and NAT Revenue, (US$, Mn), 2018-2035
Figure 26. Benelux Molecular Diagnostics and NAT Revenue, (US$, Mn), 2018-2035
Figure 27. By Region - Asia Molecular Diagnostics and NAT Revenue Market Share, 2018-2035
Figure 28. China Molecular Diagnostics and NAT Revenue, (US$, Mn), 2018-2035
Figure 29. Japan Molecular Diagnostics and NAT Revenue, (US$, Mn), 2018-2035
Figure 30. South Korea Molecular Diagnostics and NAT Revenue, (US$, Mn), 2018-2035
Figure 31. Southeast Asia Molecular Diagnostics and NAT Revenue, (US$, Mn), 2018-2035
Figure 32. India Molecular Diagnostics and NAT Revenue, (US$, Mn), 2018-2035
Figure 33. By Country - South America Molecular Diagnostics and NAT Revenue Market Share, 2018-2035
Figure 34. Brazil Molecular Diagnostics and NAT Revenue, (US$, Mn), 2018-2035
Figure 35. Argentina Molecular Diagnostics and NAT Revenue, (US$, Mn), 2018-2035
Figure 36. By Country - Middle East & Africa Molecular Diagnostics and NAT Revenue Market Share, 2018-2035
Figure 37. Turkey Molecular Diagnostics and NAT Revenue, (US$, Mn), 2018-2035
Figure 38. Israel Molecular Diagnostics and NAT Revenue, (US$, Mn), 2018-2035
Figure 39. Saudi Arabia Molecular Diagnostics and NAT Revenue, (US$, Mn), 2018-2035
Figure 40. UAE Molecular Diagnostics and NAT Revenue, (US$, Mn), 2018-2035
Figure 41. Roche Molecular Diagnostics and NAT Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Abbott Molecular Diagnostics and NAT Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. BD Molecular Diagnostics and NAT Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Biomerieux Molecular Diagnostics and NAT Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Qiagen Molecular Diagnostics and NAT Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Thermo Fisher Scientific Molecular Diagnostics and NAT Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Agilent Molecular Diagnostics and NAT Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. GenMark Molecular Diagnostics and NAT Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Siemens Healthcare Molecular Diagnostics and NAT Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. AutoGenomics Molecular Diagnostics and NAT Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
